158 related articles for article (PubMed ID: 22809434)
1. Mutation analysis of isocitrate dehydrogenase in acute lymphoblastic leukemia.
Zhang Y; Wei H; Tang K; Lin D; Zhang C; Mi Y; Wang L; Wang C; Wang M; Wang J
Genet Test Mol Biomarkers; 2012 Aug; 16(8):991-5. PubMed ID: 22809434
[TBL] [Abstract][Full Text] [Related]
2. IDH1 and IDH2 mutations in pediatric acute leukemia.
Andersson AK; Miller DW; Lynch JA; Lemoff AS; Cai Z; Pounds SB; Radtke I; Yan B; Schuetz JD; Rubnitz JE; Ribeiro RC; Raimondi SC; Zhang J; Mullighan CG; Shurtleff SA; Schulman BA; Downing JR
Leukemia; 2011 Oct; 25(10):1570-7. PubMed ID: 21647154
[TBL] [Abstract][Full Text] [Related]
3. IDH1 and IDH2 mutation analysis in Chinese patients with acute myeloid leukemia and myelodysplastic syndrome.
Lin J; Yao DM; Qian J; Chen Q; Qian W; Li Y; Yang J; Wang CZ; Chai HY; Qian Z; Xiao GF; Xu WR
Ann Hematol; 2012 Apr; 91(4):519-25. PubMed ID: 21997850
[TBL] [Abstract][Full Text] [Related]
4. Acquired mutations in the genes encoding IDH1 and IDH2 both are recurrent aberrations in acute myeloid leukemia: prevalence and prognostic value.
Abbas S; Lugthart S; Kavelaars FG; Schelen A; Koenders JE; Zeilemaker A; van Putten WJ; Rijneveld AW; Löwenberg B; Valk PJ
Blood; 2010 Sep; 116(12):2122-6. PubMed ID: 20538800
[TBL] [Abstract][Full Text] [Related]
5. The Frequency and clinical significance of IDH1 mutations in Chinese acute myeloid leukemia patients.
Guan L; Gao L; Wang L; Li M; Yin Y; Yu L; Gao C
PLoS One; 2013; 8(12):e83334. PubMed ID: 24376688
[TBL] [Abstract][Full Text] [Related]
6. Isocitrate dehydrogenase mutation hot spots in acute lymphoblastic leukemia and oral cancer.
Tang JY; Chang CC; Lin PC; Chang JG
Kaohsiung J Med Sci; 2012 Mar; 28(3):138-44. PubMed ID: 22385606
[TBL] [Abstract][Full Text] [Related]
7. IDH1 mutations in patients with myelodysplastic syndromes are associated with an unfavorable prognosis.
Thol F; Weissinger EM; Krauter J; Wagner K; Damm F; Wichmann M; Göhring G; Schumann C; Bug G; Ottmann O; Hofmann WK; Schlegelberger B; Ganser A; Heuser M
Haematologica; 2010 Oct; 95(10):1668-74. PubMed ID: 20494930
[TBL] [Abstract][Full Text] [Related]
8. IDH1 and IDH2 mutations are frequent in Chinese patients with acute myeloid leukemia but rare in other types of hematological disorders.
Zou Y; Zeng Y; Zhang DF; Zou SH; Cheng YF; Yao YG
Biochem Biophys Res Commun; 2010 Nov; 402(2):378-83. PubMed ID: 20946881
[TBL] [Abstract][Full Text] [Related]
9. [Clinical significance of IDH1 and IDH2 mutations in patients with acute myeloid leukemia].
Mi RH; Lu XD; Wei XD; Fan RH; Yin QS; Hu JY; Wang Q; Song YP
Zhonghua Xue Ye Xue Za Zhi; 2011 Sep; 32(9):610-3. PubMed ID: 22338155
[TBL] [Abstract][Full Text] [Related]
10. Rapid and reliable detection of IDH1 R132 mutations in acute myeloid leukemia using high-resolution melting curve analysis.
Lin J; Qian J; Yao DM; Li Y; Yang J; Chen Q; Chai HY; Xiao GF; Xu WR
Clin Biochem; 2011 Jul; 44(10-11):779-83. PubMed ID: 21539821
[TBL] [Abstract][Full Text] [Related]
11. Oncogenetic landscape and clinical impact of IDH1 and IDH2 mutations in T-ALL.
Simonin M; Schmidt A; Bontoux C; Dourthe MÉ; Lengliné E; Andrieu GP; Lhermitte L; Graux C; Grardel N; Cayuela JM; Huguet F; Arnoux I; Ducassou S; Macintyre E; Gandemer V; Dombret H; Petit A; Ifrah N; Baruchel A; Boissel N; Asnafi V
J Hematol Oncol; 2021 May; 14(1):74. PubMed ID: 33941203
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and prognostic value of IDH1 and IDH2 mutations in childhood AML: a study of the AML-BFM and DCOG study groups.
Damm F; Thol F; Hollink I; Zimmermann M; Reinhardt K; van den Heuvel-Eibrink MM; Zwaan CM; de Haas V; Creutzig U; Klusmann JH; Krauter J; Heuser M; Ganser A; Reinhardt D; Thiede C
Leukemia; 2011 Nov; 25(11):1704-10. PubMed ID: 21647152
[TBL] [Abstract][Full Text] [Related]
13. Acquired somatic mutations of isocitrate dehydrogenases 1 and 2 (IDH1 and IDH2) in preleukemic disorders.
Chotirat S; Thongnoppakhun W; Wanachiwanawin W; Auewarakul CU
Blood Cells Mol Dis; 2015 Mar; 54(3):286-91. PubMed ID: 25486927
[TBL] [Abstract][Full Text] [Related]
14. Isocitrate dehydrogenase mutations in myeloid malignancies.
Medeiros BC; Fathi AT; DiNardo CD; Pollyea DA; Chan SM; Swords R
Leukemia; 2017 Feb; 31(2):272-281. PubMed ID: 27721426
[TBL] [Abstract][Full Text] [Related]
15. Molecular alterations of the IDH1 gene in AML: a Children's Oncology Group and Southwest Oncology Group study.
Ho PA; Alonzo TA; Kopecky KJ; Miller KL; Kuhn J; Zeng R; Gerbing RB; Raimondi SC; Hirsch BA; Oehler V; Hurwitz CA; Franklin JL; Gamis AS; Petersdorf SH; Anderson JE; Reaman GH; Baker LH; Willman CL; Bernstein ID; Radich JP; Appelbaum FR; Stirewalt DL; Meshinchi S
Leukemia; 2010 May; 24(5):909-13. PubMed ID: 20376086
[TBL] [Abstract][Full Text] [Related]
16. IDH mutations in glioma and acute myeloid leukemia.
Dang L; Jin S; Su SM
Trends Mol Med; 2010 Sep; 16(9):387-97. PubMed ID: 20692206
[TBL] [Abstract][Full Text] [Related]
17. [Isocitrate dehydrogenase gene mutations in acute myeloid leukemia].
Zhou XJ; Zhang SJ; Qiao C; Shen YF; Li JY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Aug; 19(4):902-6. PubMed ID: 21867611
[TBL] [Abstract][Full Text] [Related]
18.
Srinivasan A; Zhou Y; Scordino T; Prabhu S; Wierenga A; Simon G; Wierenga KJ; Thompson J; Shah R; Sinha AA
Pediatr Hematol Oncol; 2020 Aug; 37(5):431-437. PubMed ID: 32166993
[TBL] [Abstract][Full Text] [Related]
19. Differential prognostic effect of IDH1 versus IDH2 mutations in myelodysplastic syndromes: a Mayo Clinic study of 277 patients.
Patnaik MM; Hanson CA; Hodnefield JM; Lasho TL; Finke CM; Knudson RA; Ketterling RP; Pardanani A; Tefferi A
Leukemia; 2012 Jan; 26(1):101-5. PubMed ID: 22033490
[TBL] [Abstract][Full Text] [Related]
20. Investigation of Isocitrate Dehydrogenase 1 and 2 Mutations in Acute Leukemia Patients in Saudi Arabia.
Alkhatabi H; Bin Saddeq HA; Alyamani L; Shinawi T; Yasin EB; Alserihi R; Felimban R; Tayeb HH; Mimani R; Alalla Z; Abu-Elmagd M; Abuzenadah A
Genes (Basel); 2021 Dec; 12(12):. PubMed ID: 34946913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]